Search Results - "Hamers, Patricia A H"
-
1
External Validation of the Colon Life Nomogram for Predicting 12-Week Mortality in Dutch Metastatic Colorectal Cancer Patients Treated with Trifluridine/Tipiracil in Daily Practice
Published in Cancers (18-10-2022)“…Background: Predicting prognosis in refractory metastatic colorectal cancer (mCRC) patients is needed to guide decision making. The Colon Life nomogram was…”
Get full text
Journal Article -
2
Informing metastatic colorectal cancer patients by quantifying multiple scenarios for survival time based on real‐life data
Published in International journal of cancer (15-01-2021)“…Reported median overall survival (mOS) in metastatic colorectal cancer (mCRC) patients participating in systemic therapy trials has increased to over 30…”
Get full text
Journal Article -
3
Impact of colorectal cancer screening on survival after metachronous metastasis
Published in European journal of cancer (1990) (01-01-2024)“…An increasing proportion of colorectal cancer (CRC) cases in Europe are detected by screening with faecal immunochemical testing (FIT). Previous studies showed…”
Get full text
Journal Article -
4
Survival of patients with deficient mismatch repair metastatic colorectal cancer in the pre-immunotherapy era
Published in British journal of cancer (19-01-2021)“…Background Metastatic colorectal cancer patients with deficient mismatch repair (dMMR mCRC) benefit from immunotherapy. Interpretation of the single-arm…”
Get full text
Journal Article -
5
Quality of Life and Survival of Metastatic Colorectal Cancer Patients Treated With Trifluridine-Tipiracil (QUALITAS)
Published in Clinical colorectal cancer (01-06-2022)“…The RECOURSE trial demonstrated a modest benefit in overall survival (OS) for trifluridine/tipiracil (FTD/TPI) versus placebo in pretreated metastatic…”
Get full text
Journal Article -
6
Trends in Use and Perceptions About Triplet Chemotherapy Plus Bevacizumab for Metastatic Colorectal Cancer
Published in JAMA network open (01-09-2021)“…Triplet chemotherapy with fluorouracil, folinic acid, oxaliplatin, and irinotecan plus bevacizumab (FOLFOXIRI-B) is an effective first-line treatment option…”
Get full text
Journal Article -
7
An ICU patient with spots and a peculiar pneumonia
Published in BMJ case reports (20-03-2013)“…This is the first report of varicella zoster virus (VZV) pneumonia in an adult patient treated with rituximab because of autoimmune haemolytic anaemia and it…”
Get full text
Journal Article -
8
An ICU patient with spots and a peculiar pneumonia
Published in BMJ Case Reports (2013)“…This is the first report of varicella zoster virus (VZV) pneumonia in an adult patient treated with rituximab because of autoimmune haemolytic anaemia and it…”
Get full text
Report